← Back to Search

Cardiovascular Health Promotion for Prevention of Heart Disease and Childhood Obesity (ENRICH Trial)

N/A
Recruiting
Led By Ian M Paul, MD, MSc
Research Sponsored by Penn State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

ENRICH Trial Summary

This trial tests adding a heart health module to a nurse home visit program to help people in Pennsylvania stay healthy.

Who is the study for?
This trial is for mothers over 18 with newborns under one month old, enrolled in the Nurse Family Partnership program in Central Pennsylvania. They must speak English and have reliable internet access. The baby should be born at or after 35 weeks' gestation.Check my eligibility
What is being tested?
The study tests adding a cardiovascular health module to an existing home visitation program by nurses. It focuses on early intervention to improve heart health for both mothers and their children in the Northern Appalachian region.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medications, traditional side effects are not expected. However, there may be indirect impacts on lifestyle choices that could affect mother and child.

ENRICH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of integration of a cardiovascular health module into the existing Nurse-Family Partnership (NFP) home visiting program.
Secondary outcome measures
Number of participants completing maternal feeding data collection
Number of participants consenting to participate in the pilot study.
Participant intervention acceptability.
+1 more

ENRICH Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
All participants will be enrolled into the intervention arm of this pilot study.

Find a Location

Who is running the clinical trial?

Penn State UniversityLead Sponsor
355 Previous Clinical Trials
125,717 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,840 Previous Clinical Trials
47,852,084 Total Patients Enrolled
Ian M Paul, MD, MScPrincipal InvestigatorPenn State University
9 Previous Clinical Trials
2,364 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are enrolled in this research program?

"Affirmative. According to clinicaltrials.gov, this experimental trial is presently seeking participants. It was initially posted on August 1st 2023 and was most recently updated on November 14th 2023. The study requires 40 volunteers from 2 research sites."

Answered by AI

Are there any vacancies for this trial open to applicants?

"According to information published on clinicaltrials.gov, this clinical trial is actively seeking eligible participants. The study was launched on August 1st 2023 and its details were amended as recently as November 14th of the same year."

Answered by AI
~17 spots leftby Dec 2024